Read our latest press releases, hear our most recent media appearances, and see which upcoming events we are attending.
Subscribe to our social channels to ensure you get our updates, news and announcements as and when they happen.
World-leading drug discovery organisations Charles River Laboratories and Evotec join the Psychiatry Consortium as drug discovery and development partners.
LUNAC Therapeutics (LUNAC) along with the Medicines Discovery Catapult and the University of Leeds, has been awarded £3.14M funding.
Medicines Discovery Catapult recognised at the Bionow Annual Awards 2019, being a finalist for the Bionow Technical Service Award for their Pre-clinical Imaging service.
Strategic collaboration will enable preclinical assessment and inform clinical development strategy for Redx’s Porcupine (RXC006) and ROCK2 inhibitors for fibrotic diseases with high unmet medical need.
Improving lives by enabling discoveries through health data
Psychiatry Consortium announces its first call for projects that focus on the identification of novel drug targets to address the unmet therapeutic needs of people with mental health conditions.
See how we can help support you with your next drug discovery project.
Speak to us
